Tumor microenvironment of metastasis in human breast carcinoma: A potential prognostic marker linked to hematogenous dissemination

Brian D. Robinson, Gabriel L. Sica, Yi Fang Liu, Thomas E. Rohan, Frank B. Gertler, John S. Condeelis, Joan G. Jones

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

Purpose: Multiphoton-based intravital imaging has shown that invasive carcinoma cells in mouse and rat mammary tumors intravasate when associated with perivascular macrophages, identifying a potential tumor microenvironment of metastasis (TMEM). We defineTMEM as the tripartite arrangement of an invasive carcinoma cell, a macrophage, and an endothelial cell. The aim of this study was to determine if TMEM density in human breast carcinoma samples predicts the development of systemic, hematogenous metastases. Experimental Design: A case-control study of 30 patients who developed metastatic breast cancer and 30 patients without metastatic disease was done. Cases were matched to controls based on currently used prognostic criteria. Paraffin-embedded primary breast cancer samples were stained using a triple immunohistochemical method allowing simultaneous identification of carcinoma cells, macrophages, and endothelial cells. Two pathologists, blinded to outcome, evaluated the number of TMEM per 20 high-power fields. Results: No association was seen between TMEM density and tumor size or grade, lymph node metastasis, lymphovascular invasion, or hormone receptor status. TMEM density was greater in the group of patients who developed systemic metastases compared with the patients with only localized breast cancer (median, 105 versus 50, respectively; P = 0.00006). For every 10-unit increase in TMEM density, the odds ratio for systemic metastasis was 1.9 (95% confidence interval, 1.1-3.4). Conclusions: TMEM density predicted the development of systemic, hematogenous metastases. The ability of TMEM to predict distant metastasis was independent of lymph node status and other currently used prognosticators. Quantitation of TMEM may be a useful new prognostic marker for breast cancer patients.

Original languageEnglish (US)
Pages (from-to)2433-2441
Number of pages9
JournalClinical Cancer Research
Volume15
Issue number7
DOIs
StatePublished - Apr 1 2009

Fingerprint

Tumor Microenvironment
Breast Neoplasms
Neoplasm Metastasis
Macrophages
Carcinoma
Endothelial Cells
Lymph Nodes
Paraffin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor microenvironment of metastasis in human breast carcinoma : A potential prognostic marker linked to hematogenous dissemination. / Robinson, Brian D.; Sica, Gabriel L.; Liu, Yi Fang; Rohan, Thomas E.; Gertler, Frank B.; Condeelis, John S.; Jones, Joan G.

In: Clinical Cancer Research, Vol. 15, No. 7, 01.04.2009, p. 2433-2441.

Research output: Contribution to journalArticle

Robinson, Brian D. ; Sica, Gabriel L. ; Liu, Yi Fang ; Rohan, Thomas E. ; Gertler, Frank B. ; Condeelis, John S. ; Jones, Joan G. / Tumor microenvironment of metastasis in human breast carcinoma : A potential prognostic marker linked to hematogenous dissemination. In: Clinical Cancer Research. 2009 ; Vol. 15, No. 7. pp. 2433-2441.
@article{037f8442e57c403eae324cca4e6eb213,
title = "Tumor microenvironment of metastasis in human breast carcinoma: A potential prognostic marker linked to hematogenous dissemination",
abstract = "Purpose: Multiphoton-based intravital imaging has shown that invasive carcinoma cells in mouse and rat mammary tumors intravasate when associated with perivascular macrophages, identifying a potential tumor microenvironment of metastasis (TMEM). We defineTMEM as the tripartite arrangement of an invasive carcinoma cell, a macrophage, and an endothelial cell. The aim of this study was to determine if TMEM density in human breast carcinoma samples predicts the development of systemic, hematogenous metastases. Experimental Design: A case-control study of 30 patients who developed metastatic breast cancer and 30 patients without metastatic disease was done. Cases were matched to controls based on currently used prognostic criteria. Paraffin-embedded primary breast cancer samples were stained using a triple immunohistochemical method allowing simultaneous identification of carcinoma cells, macrophages, and endothelial cells. Two pathologists, blinded to outcome, evaluated the number of TMEM per 20 high-power fields. Results: No association was seen between TMEM density and tumor size or grade, lymph node metastasis, lymphovascular invasion, or hormone receptor status. TMEM density was greater in the group of patients who developed systemic metastases compared with the patients with only localized breast cancer (median, 105 versus 50, respectively; P = 0.00006). For every 10-unit increase in TMEM density, the odds ratio for systemic metastasis was 1.9 (95{\%} confidence interval, 1.1-3.4). Conclusions: TMEM density predicted the development of systemic, hematogenous metastases. The ability of TMEM to predict distant metastasis was independent of lymph node status and other currently used prognosticators. Quantitation of TMEM may be a useful new prognostic marker for breast cancer patients.",
author = "Robinson, {Brian D.} and Sica, {Gabriel L.} and Liu, {Yi Fang} and Rohan, {Thomas E.} and Gertler, {Frank B.} and Condeelis, {John S.} and Jones, {Joan G.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1158/1078-0432.CCR-08-2179",
language = "English (US)",
volume = "15",
pages = "2433--2441",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Tumor microenvironment of metastasis in human breast carcinoma

T2 - A potential prognostic marker linked to hematogenous dissemination

AU - Robinson, Brian D.

AU - Sica, Gabriel L.

AU - Liu, Yi Fang

AU - Rohan, Thomas E.

AU - Gertler, Frank B.

AU - Condeelis, John S.

AU - Jones, Joan G.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Purpose: Multiphoton-based intravital imaging has shown that invasive carcinoma cells in mouse and rat mammary tumors intravasate when associated with perivascular macrophages, identifying a potential tumor microenvironment of metastasis (TMEM). We defineTMEM as the tripartite arrangement of an invasive carcinoma cell, a macrophage, and an endothelial cell. The aim of this study was to determine if TMEM density in human breast carcinoma samples predicts the development of systemic, hematogenous metastases. Experimental Design: A case-control study of 30 patients who developed metastatic breast cancer and 30 patients without metastatic disease was done. Cases were matched to controls based on currently used prognostic criteria. Paraffin-embedded primary breast cancer samples were stained using a triple immunohistochemical method allowing simultaneous identification of carcinoma cells, macrophages, and endothelial cells. Two pathologists, blinded to outcome, evaluated the number of TMEM per 20 high-power fields. Results: No association was seen between TMEM density and tumor size or grade, lymph node metastasis, lymphovascular invasion, or hormone receptor status. TMEM density was greater in the group of patients who developed systemic metastases compared with the patients with only localized breast cancer (median, 105 versus 50, respectively; P = 0.00006). For every 10-unit increase in TMEM density, the odds ratio for systemic metastasis was 1.9 (95% confidence interval, 1.1-3.4). Conclusions: TMEM density predicted the development of systemic, hematogenous metastases. The ability of TMEM to predict distant metastasis was independent of lymph node status and other currently used prognosticators. Quantitation of TMEM may be a useful new prognostic marker for breast cancer patients.

AB - Purpose: Multiphoton-based intravital imaging has shown that invasive carcinoma cells in mouse and rat mammary tumors intravasate when associated with perivascular macrophages, identifying a potential tumor microenvironment of metastasis (TMEM). We defineTMEM as the tripartite arrangement of an invasive carcinoma cell, a macrophage, and an endothelial cell. The aim of this study was to determine if TMEM density in human breast carcinoma samples predicts the development of systemic, hematogenous metastases. Experimental Design: A case-control study of 30 patients who developed metastatic breast cancer and 30 patients without metastatic disease was done. Cases were matched to controls based on currently used prognostic criteria. Paraffin-embedded primary breast cancer samples were stained using a triple immunohistochemical method allowing simultaneous identification of carcinoma cells, macrophages, and endothelial cells. Two pathologists, blinded to outcome, evaluated the number of TMEM per 20 high-power fields. Results: No association was seen between TMEM density and tumor size or grade, lymph node metastasis, lymphovascular invasion, or hormone receptor status. TMEM density was greater in the group of patients who developed systemic metastases compared with the patients with only localized breast cancer (median, 105 versus 50, respectively; P = 0.00006). For every 10-unit increase in TMEM density, the odds ratio for systemic metastasis was 1.9 (95% confidence interval, 1.1-3.4). Conclusions: TMEM density predicted the development of systemic, hematogenous metastases. The ability of TMEM to predict distant metastasis was independent of lymph node status and other currently used prognosticators. Quantitation of TMEM may be a useful new prognostic marker for breast cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=65249126907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249126907&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-08-2179

DO - 10.1158/1078-0432.CCR-08-2179

M3 - Article

C2 - 19318480

AN - SCOPUS:65249126907

VL - 15

SP - 2433

EP - 2441

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 7

ER -